Total planned funding: $624,863,134
Clear active filters
Chemonics International
HTXD: Treatment: ARV Drugs
2010
2011
2012
2013
2014
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $165,163,959 |
Tanzania | $124,251,261 |
Zambia | $117,085,653 |
Mozambique | $42,384,612 |
Zimbabwe | $38,775,231 |
Uganda | $35,092,941 |
Democratic Republic of the Congo | $31,959,226 |
Haiti | $22,557,669 |
Rwanda | $19,489,758 |
Vietnam | $7,554,318 |
Eswatini | $5,800,169 |
Côte d'Ivoire | $4,129,279 |
Burundi | $3,438,296 |
Ukraine | $2,605,290 |
West Africa Region | $2,012,397 |
Namibia | $1,075,000 |
Lesotho | $482,041 |
Botswana | $331,279 |
Western Hemisphere Region | $309,202 |
Asia Regional Program | $175,500 |
Cameroon | $146,025 |
South Sudan | $44,028 |
Organizational Types
Private Contractor | $624,863,134 |
Program Areas
Treatment | $624,863,134 |
Budget Codes
HTXD: Treatment: ARV Drugs | $624,863,134 |
Top Partner Programs
Chemonics International:
$624,863,134
View countries